Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

Getting a GLP-1 prescribed online in 2026 is mostly a paperwork problem, not a medical one. The clinical bar is well-defined — BMI ≥ 30, or BMI ≥ 27 with a weight-related condition; no personal or family history of medullary thyroid carcinoma or MEN 2; not pregnant; review of pancreatitis, gallbladder, and kidney history. The friction lives elsewhere: choosing a legitimate prescriber, picking the right pathway (insurance vs cash-pay branded vs cash-pay compounded), verifying the pharmacy, navigating prior authorization, and titrating the dose without abandoning treatment in week three. This guide walks the actual telehealth pathway end to end and shows where the PlexusDx Semaglutide Injection Protocol, Tirzepatide Injection Protocol, and Microdose GLP-1 Protocol sit on the cash-pay side — async intake in 45 states, scheduled live consult in the 5 states that require it, no membership fee, and an optional Precision Peptide Genetic Test that anchors the dose conversation to your GIPR, GLP1R, FTO, MC4R, and TCF7L2 variants instead of population averages.

The fast answer: yes, you can get GLP-1 prescribed online

A licensed clinician can evaluate you remotely, confirm eligibility, write a prescription, and route it to a pharmacy without an in-person visit in every U.S. state. The full sequence is: confirm eligibility → pick a pathway → complete intake → consult (async messaging, video, or phone depending on platform and state law) → labs if the clinician needs them → prescription sent to a verified pharmacy → titration with structured follow-up. Most legitimate telehealth services can complete the evaluation within 24–48 hours; medication delivery typically follows in 3–7 days for mail-order. PlexusDx Weight Management Protocols use async intake in 45 states and a scheduled live consult in the 5 states that require synchronous evaluation under their telehealth rules; either way, the clinical bar — the same FDA labeling, contraindications, and titration logic — is identical.

The 2-minute eligibility self-screen

Before paying for a visit, run this filter against the FDA labeling for chronic weight management. BMI: ≥ 30 generally meets criteria; 27–29.9 may qualify with at least one weight-related condition (hypertension, dyslipidemia, type 2 diabetes or prediabetes, obstructive sleep apnea, cardiovascular disease, or MASLD); under 27 typically does not meet the weight-management indication. Hard stops — do not request a GLP-1 prescription if any apply: personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), pregnancy, or a known serious allergy to the medication or its excipients. Discuss-first cautions: history of pancreatitis, active gallbladder disease, kidney issues with dehydration risk, severe gastroparesis or other GI motility disease. The boxed warning for thyroid C-cell tumors applies to both semaglutide and tirzepatide based on rodent studies; that warning is on every U.S. label and applies to compounded versions of the same active ingredients as well. If you pass this screen, you’re in the group that telehealth platforms — PlexusDx included — will evaluate.

The three pathways — insurance, branded cash-pay, compounded cash-pay

Every legitimate online GLP-1 prescribing path is one of these three. Path A — insurance route: a prescriber experienced with prior authorization documents your BMI, comorbidities, and prior weight-loss attempts and submits to your plan. If approved, you fill Wegovy, Zepbound, or Saxenda at a copay. Coverage is plan-specific and most commercial plans still don’t cover weight-loss GLP-1s as of 2026, so denials and appeals are common; timeline is typically 1–4 weeks. Path B — cash-pay branded: you pay the manufacturer or a partner pharmacy directly for FDA-approved Wegovy or Zepbound. List price runs roughly $1,000–$1,350/month; Lilly Direct’s self-pay Zepbound vials are about $499/month for the 2.5mg and 5mg starting doses (pricing varies and may change). Path C — cash-pay compounded: a state-licensed clinician prescribes compounded semaglutide or tirzepatide from a 503A or 503B compounding pharmacy. Compounded GLP-1s are not FDA-approved finished drug products — they are pharmacy-prepared versions of the same active ingredients. Cash-pay compounded telehealth typically runs $129–$399/month depending on protocol and dose. PlexusDx operates in this third category at $129-$369/mo across six protocols, with no membership fee layered on top.

How PlexusDx Weight Management Protocols handle the online prescribing pathway

PlexusDx compresses the standard seven-step process into a single intake: medical-history intake → state-licensed clinician review (async in 45 states; scheduled live video consult in the 5 states that require synchronous evaluation) → protocol and starting dose selected if eligible → U.S. compounding pharmacy ships directly → structured follow-up at week 4 and week 12. No membership fee. The published price is the all-inclusive monthly cost — provider time, prescription, compounded medication, and shipping in one line item. The six protocols cover the practical decision tree: Microdose GLP-1 Protocol at $129/mo flat (lowest entry cost or needle-free format); Semaglutide Oral from $249/mo (daily pill); Semaglutide Injection at $149/mo (weekly compounded semaglutide); Tirzepatide Injection at $249/mo (GIP/GLP-1 dual-agonist); Tirzepatide Oral at $279/mo; and GLP-Squared at $249/mo (clinician-titrated semaglutide-plus-tirzepatide combination).

Pharmacy verification — the single most important step you control

This is the step most patients skip. Verify the pharmacy before you let a prescription land there. For any U.S. pharmacy: check the state board of pharmacy license lookup, NABP’s Safe.Pharmacy directory, and FDA BeSafeRx. Legitimate pharmacies require a prescription, list a verifiable U.S. address, and have a state-licensed pharmacist available. Red flags: sells GLP-1 “research peptides” without a prescription, ships from outside the U.S. without disclosure, lists vague dosing in “units” rather than milligrams, no clinician contact path. 503A vs 503B: 503A pharmacies compound for individual prescriptions; 503B outsourcing facilities compound in larger batches under cGMP. Neither is FDA-approved as a finished drug product, but both are regulated. PlexusDx works with U.S.-licensed compounding pharmacies and routes prescriptions only after clinician evaluation.

What the clinician needs from you — intake, labs, and follow-up

Most online intakes ask for weight and height, a medication list, a medical-history summary covering the contraindications above, prior weight-loss attempts, and any recent labs you have on hand. Some clinicians require fresh labs before titrating — HbA1c, lipid panel, comprehensive metabolic panel for kidney and liver function, sometimes a TSH or pregnancy test. Once the prescription is active, structured follow-up matters more than the initial visit: a typical compounded-semaglutide titration runs 0.25mg weekly × 4 weeks, then 0.5mg, 1.0mg, up to 2.0mg as tolerated; tirzepatide typically starts at 2.5mg and steps to 5, 7.5, 10, 12.5, and up to 15mg over months. Slower titration reduces the nausea, vomiting, and diarrhea that drive most early discontinuations. The PlexusDx model includes structured follow-up checkpoints so dose moves are clinician-decided rather than patient-self-escalated.

Why a genetic baseline changes the dose conversation

Population-average titration works for most patients, but a meaningful subset under-respond or over-respond to GLP-1 monotherapy in ways predicted by their genetics. The GIPR rs1800437 variant is the headline marker for differential response to tirzepatide’s GIP component; variants in GLP1R, FTO, MC4R, and TCF7L2 modify appetite regulation, satiety signaling, and insulin response in ways that affect both weight-loss trajectory and side-effect tolerability. The Precision Peptide Genetic Test reads 48 genes and 57 variants across 14 health pathways, including 34 weight-management insights, and surfaces this data through the Peptide Pathways Report in the PlexusDx Results Portal so the prescribing clinician can see whether a tirzepatide-first approach, a slower semaglutide titration, or a microdose entry point is more likely to fit your biology before week one. The test is $298 standalone, or $99 as an add-on after your first month on any protocol — which means you can start on a cash-pay protocol now and layer the genetic data into the second-month dose conversation rather than waiting on a separate testing decision before treatment begins.

Frequently asked questions

Can you really get a GLP-1 prescribed online without ever seeing a doctor in person?

Yes. Every U.S. state allows GLP-1 prescribing through telehealth when a state-licensed clinician completes an appropriate evaluation. PlexusDx uses async intake in 45 states; the 5 states whose telehealth rules require synchronous evaluation get a scheduled live video consult instead. The clinical bar — eligibility criteria, contraindications, titration logic — is identical either way.

How fast can I actually start a GLP-1 after submitting an online intake?

Most legitimate platforms complete the clinical evaluation within 24–48 hours of a complete intake, and prescriptions go out the same day if approved. Medication delivery from a U.S. compounding pharmacy is typically 3–7 days. The slowest step on the insurance pathway is prior authorization, which can run 1–4 weeks; cash-pay pathways skip that step entirely.

What is the cheapest legitimate way to get a GLP-1 prescribed online?

The PlexusDx Microdose GLP-1 Protocol is $129/mo flat all-inclusive (clinician, prescription, compounded medication, shipping — no membership) and is the lowest-cost legitimate cash-pay path among major telehealth platforms. Compounded semaglutide or tirzepatide protocols at PlexusDx run $149/mo. FDA-approved branded Wegovy or Zepbound at list price is roughly $1,000–$1,350/mo without insurance.

Do I need insurance to get GLP-1 prescribed online?

No. PlexusDx is cash-pay only and does not accept or bill insurance — the published monthly price is the total cost. If you do have plan coverage for Wegovy or Zepbound at a low copay, the insurance route through a branded telehealth platform is usually cheaper for branded medication; if you don’t, cash-pay compounded telehealth is typically the lowest-cost legitimate path.

Are compounded GLP-1 medications safe to start through an online prescription?

Compounded semaglutide and tirzepatide are not FDA-approved finished drug products — they are pharmacy-prepared versions of the same active ingredients in Wegovy and Zepbound. The FDA has issued warnings about dosing errors and salt-form variants from some sources. The risk-management answer is to verify that your prescriber is state-licensed, that the pharmacy is a U.S. 503A or 503B facility you can confirm with NABP or your state board, that dosing is in milligrams (not “units”), and that titration is clinician-managed. PlexusDx routes through licensed U.S. compounding pharmacies under that exact framework.

What if I have a contraindication — will the clinician just decline me?

Yes, and that’s the correct behavior. A clinician who prescribes through a hard contraindication (personal or family history of MTC, MEN 2, pregnancy, severe pancreatitis history) is not protecting you. PlexusDx clinicians decline ineligible patients at intake; if you’re close to the line on a discuss-first caution like prior pancreatitis or gallbladder disease, expect a longer review and possibly a request for additional records before a prescription is written.

Should I get a genetic test before or after I start a GLP-1 protocol?

Either works. Starting the test first ($298 standalone) gives the clinician the data at the initial dose decision; layering it in after month one ($99 as an add-on once you’re on any PlexusDx protocol) lets you start treatment immediately and use the genetic data to inform the first major titration decision instead. The Precision Peptide Genetic Test covers GIPR rs1800437, GLP1R, FTO, MC4R, and TCF7L2 variants alongside 34 weight-management insights through the Peptide Pathways Report.

Related reading on PlexusDx

Related reading on PlexusDx: GLP-1 Cost, Cheapest GLP-1, Semaglutide Cost, Tirzepatide Costs.

Disclaimer: This article is educational and is not medical advice. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols. Pricing for FDA-approved branded GLP-1 medications and competing telehealth platforms is based on each provider's published rates as of April 2026; actual costs may vary by state, plan, and individual eligibility. PlexusDx does not sell, prescribe, or recommend any therapeutic peptide outside the GLP-1 category covered by its protocols. Discuss any GLP-1 medication decision with a licensed clinician.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves